Information Provided By:
Fly News Breaks for March 22, 2018
ENDP
Mar 22, 2018 | 06:05 EDT
B. Riley FBR analyst David Buck continues to view Endo International's risk/reward as attractive. The analyst sees signs of stabilization for generic pricing and the company's ability to show a rebound in EBITDA into 2019 as potential upcoming catalysts for the shares. He keeps a Buy rating on Endo with a $10 price target.
News For ENDP From the Last 2 Days
There are no results for your query ENDP